Antoaneta A. Markova

Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection

Pothakamuri Venkata Suneetha, Sven Pischke, Verena Schlaphoff et al. · Hepatology · 2011 · 172 citations

Adaptive Immune System, Immunology, Cd4 T Cell Responses +17

Compromised Function of Natural Killer Cells in Acute and Chronic Viral Hepatitis

Sebastian Lunemann, David F. G. Malone, Julia Hengst et al. · The Journal of Infectious Diseases · 2013 · 116 citations

Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting

Benjamin Maasoumy, Kerstin Port, Antoaneta A. Markova et al. · PLoS ONE · 2013 · 99 citations · Full text

Hepatitis B Surface Antigen (Hbsag) Decrease and Serum Interferon-Inducible Protein-10 Levels as Predictive Markers for Hbsag Loss during Treatment with Nucleoside/Nucleotide Analogues

Jerzy Jaroszewicz, Huy Ho, Antoaneta A. Markova et al. · Antiviral Therapy · 2011 · 86 citations

The clinical significance of drug–drug interactions in the era of direct‐acting anti‐viral agents against chronic hepatitis <scp>C</scp>

Benjamin Maasoumy, Kerstin Port, B. Calle Serrano et al. · Alimentary Pharmacology & Therapeutics · 2013 · 41 citations